Basal NF-κB controls IL-7 responsiveness of quiescent naive T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7397-7402

  Miller, Michelle L ^a   Mashayekhi, Mona ^a,c   Chen, Luqiu ^a   Zhou, Ping ^a,d   Liu, Xindong ^b,e   Michelotti, Monica ^a,f   Gunn, Nicole Tramontini ^a,g   Powers, Sarah ^a,h   Zhu, Xiaoping ^b   Evaristo, Cesar ^a   Alegre, Maria Luisa ^a   Molinero, Luciana L ^a,i  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^h LEWIS UNIVERSITY   (United States)

ⁱ GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

IKBADN; IKKΒ; IL7R ENHANCER; STAT5;

ANIMALS; ANTIGENS; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-7; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B P50 SUBUNIT; RECEPTORS, INTERLEUKIN-7; RECOMBINANT PROTEINS; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 84901022839     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315398111     Document Type: Article

References (47)

1. Mackall CL, Fry TJ, Gress RE (2011) Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 11(5):330-342.
2. Kimura MY, et al. (2013) IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol 14(2):143-151.
3. Surh CD, Sprent J (2008) Homeostasis of naive and memory T cells. Immunity 29(6): 848-862.
4. Murali-Krishna K, et al. (1999) Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286(5443):1377-1381.
5. Markiewicz MA, Brown I, Gajewski TF (2003) Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL. Eur J Immunol 33(10):2917-2926.
6. Martin B, Bourgeois C, Dautigny N, Lucas B (2003) On the role of MHC class II molecules in the survival and lymphopenia-induced proliferation of peripheral CD4+ T cells. Proc Natl Acad Sci USA 100(10):6021-6026.
7. Schluns KS, Kieper WC, Jameson SC, Lefranois L (2000) Interleukin-7 mediates the homeostasis of nave and memory CD8 T cells in vivo. Nat Immunol 1(5):426-432.
8. Tan JT, et al. (2001) IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98(15):8732-8737.
9. Maraskovsky E, et al. (1996) Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol 157(12):5315-5323.
10. Tani-ichi S, et al. (2013) Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations. Proc Natl Acad Sci USA 110(2):612-617.
11. Henriques CM, Rino J, Nibbs RJ, Graham GJ, Barata JT (2010) IL-7 induces rapid clathrin- mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood 115(16):3269-3277.
12. Pallard C, et al. (1999) Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 10(5):525-535.
13. Jiang Q, et al. (2005) Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 16(4-5):513-533.
14. Park JH, et al. (2004) Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: A novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21(2):289-302.
15. Carrette F, Surh CD (2012) IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin Immunol 24(3):209-217.
16. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6):280-288.
17. Wu M, et al. (1996) Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 15(17):4682-4690.
18. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18(18):2195-2224.
19. Harlin H, Podack E, Boothby M, Alegre ML (2002) TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-Associated factor/p38 mitogenactivated protein kinase-dependent mechanism. J Immunol 169(5):2451-2459.
20. Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW (1997) Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med 185(11):1897-1907.
21. Mora AL, et al. (2003) Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: Roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ 10(9):1032-1044.
22. Molinero LL, Alegre ML (2012) Role of T cell-nuclear factor κB in transplantation. Transplant Rev (Orlando) 26(3):189-200.
23. Harlin H, et al. (2002) CTLA-4 engagement regulates NF-kappaB activation in vivo. Eur J Immunol 32(8):2095-2104.
24. Mandl JN, Monteiro JP, Vrisekoop N, Germain RN (2013) T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity 38(2):263-274.
25. Ogilvy S, et al. (1999) Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 96(26):14943-14948.
26. Voll RE, et al. (2000) NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 13(5):677-689.
27. Schmidt-Supprian M, et al. (2003) Mature T cells depend on signaling through the IKK complex. Immunity 19(3):377-389.
28. Tobe M, et al. (2003) Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation. Bioorg Med Chem 11(3):383-391.
29. Sasaki Y, et al. (2006) Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24(6):729-739.
30. Hennet T, Hagen FK, Tabak LA, Marth JD (1995) T-cell-specific deletion of a polypeptide N-Acetylgalactosaminyl-transferase gene by site-directed recombination. Proc Natl Acad Sci USA 92(26):12070-12074.
31. Molinero LL, Miller ML, Evaristo C, Alegre ML (2011) High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner. J Immunol 186(8): 4609-4617.
32. Boyman O, Krieg C, Homann D, Sprent J (2012) Homeostatic maintenance of T cells and natural killer cells. Cell Mol Life Sci 69(10):1597-1608.
33. Silva A, Cornish G, Ley SC, Seddon B (2014) NF-κB signaling mediates homeostatic maturation of new T cells. Proc Natl Acad Sci USA 111(9):E846-E855.
34. Jimi E, Strickland I, Voll RE, Long M, Ghosh S (2008) Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes. Immunity 29(4):523-537.
35. Park JH, et al. (2007) Coreceptor tuning: Cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol 8(10):1049-1059.
36. Kerdiles YM, et al. (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10(2):176-184.
37. Ouyang W, Beckett O, Flavell RA, Li MO (2009) An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30(3):358-371.
38. Grenningloh R, et al. (2011) Ets-1 maintains IL-7 receptor expression in peripheral T cells. J Immunol 186(2):969-976.
39. Lee HC, Shibata H, Ogawa S, Maki K, Ikuta K (2005) Transcriptional regulation of the mouse IL-7 receptor alpha promoter by glucocorticoid receptor. J Immunol 174(12): 7800-7806.
40. DeKoter RP, et al. (2007) Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem 282(19):14194-14204.
41. Krishna S, et al. (2012) Chronic activation of the kinase IKKβ impairs T cell function and survival. J Immunol 189(3):1209-1219.
42. Cekic C, Sag D, Day YJ, Linden J (2013) Extracellular adenosine regulates naive T cell development and peripheral maintenance. J Exp Med 210(12):2693-2706.
43. Tian B, Nowak DE, Jamaluddin M, Wang S, Brasier AR (2005) Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J Biol Chem 280(17):17435-17448.
44. Consortium EP; ENCODE Project Consortium (2011) A users guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9(4):e1001046.
45. Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107(2):135-142.
46. Schlenner SM, et al. (2010) Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 32(3):426-436.
47. Molinero LL, Fuertes MB, Rabinovich GA, Fainboim L, Zwirner NW (2002) Activationinduced expression of MICA on T lymphocytes involves engagement of CD3 and CD28. J Leukoc Biol 71(5):791-797